Carbidopa
Carbidopa (Lodosyn) is a drug given to people with Parkinson’s disease in order to inhibit peripheral metabolism oflevodopa. This property is significant in that it allows a greater proportion of peripheral levodopa to cross the blood–brain barrier for central nervous system effect.
| Catalog Number | 10-101-135 |
| Alternative Name(s) | lodosyn, CARBIDOPA 1-HYDRATE, CARBIDOPA MONOHYDRATE, (S)-3-(3,4-Dihydroxyphenyl)-2- hydrazino-2-methylpropanoic acid · H2O, (S)-α-Hydrazino-3,4-dihydroxy-α-methylbenzenepropanoic acid monohydrate, (-)-L-α-Hydrazino-3,4-dihydroxy-α-methylhydrocinnamic acid monohydrate, α-Methyldopahydrazine monohydrate, MK485, MK 485, MK-485, Carbidopa, Lodosyn |
| Research Area | Parkinson's disease |
| Molecular Formula | C10H14N2O4 |
| CAS# | 28860-95-9 |
| Purity | >98% |
| Inchi | InChI=1S/C10H14N2O4.H2O/c1-10(12-11,9(15)16)5-6-2-3-7(13)8(14)4-6;/h2-4,12-14H,5,11H2,1H3,(H,15,16);1H2/t10-;/m0./s1 |
| Inchi Key | QTAOMKOIBXZKND-PPHPATTJSA-N |
| SMILES | C[C@](CC1=CC(=C(C=C1)O)O)(C(=O)O)NN.O |
| Size | Inquiry |
| Supplier Page | https://www.creative-peptides.com/product/carbidopa-item-10-101-135-25.html |